Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivityArticle Published on 2022-07-012022-11-16 Journal: Pediatric blood & cancer [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome ALL allergy coronavirus coronavirus disease counseling COVID COVID vaccine COVID-19 COVID-19 vaccination COVID-19 vaccine effective excluded glycol hypersensitivity LLy mRNA COVID-19 vaccines mRNA vaccine mRNA-based COVID-19 vaccine oncologist oncology patients outcome Patient pegasparaginase. Prevent receive receiving Safe SARS-CoV-2 SARS-CoV-2 vaccination vaccination Vaccine [DOI] 10.1002/pbc.29686 PMC 바로가기
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection전신 및 점막 IgA 반응은 SARS-CoV-2 mRNA 백신 접종에 대한 반응으로 다양하게 유도되며 후속 감염에 대한 보호와 관련이 있습니다.Article Published on 2022-05-012022-09-11 Journal: Mucosal Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술, [키워드] anti-SARS-CoV-2 Anti-spike booster Breakthrough infection breakthrough infections collected comparable COVID-19 COVID-19 mRNA Vaccination COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines dose elicit Examining exhibited groups IgA IgA response IgG IgG level IgG levels in some infect infected with SARS-CoV-2 Infection Kinetics kinetics of antibody Local mRNA mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNA vaccination mucosal IgA response oral cavity participant Participants persist positive preventing infection prospective cohort provoke RBD RBD IgA receiving reduce respiratory Saliva SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants second dose serum subsequent systemic These data Transmission upper respiratory tract utility [DOI] 10.1038/s41385-022-00511-0 PMC 바로가기 [Article Type] Article
Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative백신 접종을 받은 암 환자의 획기적인 COVID-19 감염의 위험과 결과: 국가 COVID 코호트 협력의 실제 증거Article Published on 2022-05-012022-09-11 Journal: Journal of clinical oncology : official journal of [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age analyzed BNT162b2 BNT162b2 vaccine Bone marrow Bone marrow transplantation booster Breakthrough infection breakthrough infections Cancer cancers Cohort controls COVID COVID-19 COVID-19 case COVID-19 cases COVID-19 infection COVID-19 infections Evidence hematologic Hematologic malignancy higher risk identify immunosuppressive effect increased risk leukemia Logistic regression lymphoid lymphoma malignancies medications Moderna mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNA-1273 Multiple myeloma Myeloma National new SARS-CoV-2 Odds ratios outcome outcomes Patient patients Patients with cancer Pfizer ranged risk SARS-COV-2 infection SARS-CoV-2 variants Sex significantly higher smoking smoking status Solid solid tumors Tumor tumors vaccination Vaccine vaccine dose variants was reduced [DOI] 10.1200/JCO.21.02419 PMC 바로가기 [Article Type] Article
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?COVID-19 백신 접종 후 SARS-CoV-2 항체가 모유에서 검출될 수 있습니까?Article Published on 2022-04-302022-09-11 Journal: Journal of the Pediatric Infectious Diseases Socie [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Against analyzed anti-SARS-CoV-2 antibody Antibody titers Antibody Units association authors benefit binding antibody unit binding antibody units BNT162b2 BNT162b2 mRNA Breastfeeding children Clinical outcome Concentration conducted control group coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine domain dose Effectiveness evaluated Factors gold gold standard HCW HCWs healthcare worker Human human milk IgA IgG IgG level IgG levels IgM immune response immune responses Immunity immunization Immunoglobulin immunoglobulin A Immunoglobulin G immunoglobulin M in vitro include independent ineligible Infant Infants Infection Influenza lack lactation limitation linear milk mother mRNA mRNA COVID-19 vaccines mRNA-1273 Multiple regression neutralization tests Neutralizing antibody titer neutralizing antibody titers nucleocapsid protein nutrition pandemic participant Participants plaque reduction neutralization positive correlation predicted Prospective Study Protein receipt receiving recipient reported Research respiratory S1 IgG SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody serology serum subgroup analysis Support transfer vaccination Vaccines was performed women [DOI] 10.1093/jpids/piac024 PMC 바로가기 [Article Type] Article
COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram스크리닝 유방 조영술에서 코로나19 백신 관련 무증상 겨드랑이 림프절병증Article Published on 2022-04-012022-09-11 Journal: Academic radiology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] average Axillary Lymphadenopathy baseline benefit cancer diagnosis COVID-19 COVID-19 vaccination COVID-19 vaccine criteria diagnostic elicit elicited evaluate exhibited HIPAA immune response ipsilateral Lymphadenopathy malignancy mammogram mammography material Moderna mRNA COVID-19 vaccine mRNA COVID-19 vaccines Patient Pfizer Pfizer-BioNTech Prevalence recalled receive resolved robust Screening second dose significantly higher significantly more study inclusion Subclinical the vaccine vaccination Vaccine Vaccines were excluded while women [DOI] 10.1016/j.acra.2021.11.010 PMC 바로가기 [Article Type] Article
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity ReactionPfizer-BioNTech mRNA COVID-19 백신(BNT162b2, Comirnaty)의 초기 투여 후 치명적인 전격성 괴사성 호산구성 심근염의 첫 번째 확인된 사례: 극히 드문 특발성 과민 반응Case Reports Published on 2022-04-012022-09-12 Journal: Journal of Clinical Immunology [Category] 진단, [키워드] adverse event adverse events Autopsy benefit BNT162b2 cause Complete Complication COVID-19 COVID-19 infection COVID-19 vaccines death described drug early diagnosis eosinophil Eosinophilic eosinophilic myocarditis facilitate first dose fulminant Hospital admission hypersensitivity hypersensitivity reaction Identified Intervention less male Mild mortality risk mRNA mRNA COVID-19 vaccines mRNA-based myocarditis Myopericarditis non-specific clinical feature observation occurred Other Pfizer-BioNTech reaction risk second dose Transient Treatment triggered vaccination Vaccine variety [DOI] 10.1007/s10875-021-01187-0 PMC 바로가기 [Article Type] Case Reports
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccinesObservational Study Published on 2022-03-022022-10-05 Journal: European heart journal. Quality of care & clinical [Category] SARS, 임상, [키워드] 95% CI 95% confidence interval age calculated database demonstrated determine dose first dose increase increased risk mRNA COVID-19 vaccine mRNA COVID-19 vaccines myocarditis Myocarditis • Pericarditis • Tozinameran • Elasomeran • Pharmacovigilance • mRNA COVID-19 vaccines. no difference Odds ratio performed Pericarditis pharmacovigilance raised recorded Registered Reporting risk second dose Sex significant difference vaccination Vaccine while World Health Organization [DOI] 10.1093/ehjqcco/qcab090 PMC 바로가기 [Article Type] Observational Study
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative StudyBrief Report Published on 2022-01-252022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] age assessment BNT162b2 BNT162b2 vaccine Comparative COVID-19 group highest immune response individual investigated levels of antibody magnitude median Moderna-mRNA-1273 mRNA COVID-19 vaccines mRNA-1273 NAb NAbs naïve Neutralizing antibodies neutralizing antibody of BNT162b2 offer Older age Pfizer-BNT162b2 produced protective immunity reducing response SARS-CoV-2 second dose shown significantly higher Spread vaccination Vaccine [DOI] 10.3390/vaccines10020191 PMC 바로가기 [Article Type] Brief Report
The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysisResearch Published on 2022-01-172022-11-01 Journal: Clinical and Molecular Allergy : CMA [Category] COVID-19, [키워드] 95% CI 95% confidence interval allergic Analysis anaphylactic Anaphylactic reaction anaphylactic shock anaphylactoid anaphylaxis article BNT162b2 vaccine calculate Canada Coronavirus infection COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine database effect sizes eight European female incidence induce Meta-analysis mRNA COVID-19 vaccines occur outcomes random effect Reactions reported Result risk SARS-CoV-2 searched severe allergic reaction Shock statistically significant union United Kingdom used data vaccination Vaccines Web of Science were used [DOI] 10.1186/s12948-022-00167-y PMC 바로가기 [Article Type] Research
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies다양한 질병 조절 요법으로 치료받는 다발성 경화증 환자에서 mRNA COVID-19 백신의 면역원성과 안전성Article Published on 2022-01-012022-09-11 Journal: Neurotherapeutics : the journal of the American So [Category] SARS, 진단, 치료기술, [키워드] Alemtuzumab Cladribine correlation COVID-19 COVID-19 vaccination detect develop Disease-modifying therapies drugs evaluated fatigue fingolimod Hospitalization humoral humoral immune response Humoral response IgG immune response immunoassay immunogenicity injection injection site Microparticle MONITOR mRNA COVID-19 vaccine mRNA COVID-19 vaccines Multiple multiple sclerosis Natalizumab Ocrelizumab Pain Patient patients treated positively correlated reduce reported Safe SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 nucleoprotein second dose Side effect significantly lower therapy treated Treatment vaccination was tested [DOI] 10.1007/s13311-021-01165-9 PMC 바로가기 [Article Type] Article